| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/29/2008 | US7364862 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/29/2008 | US7364860 Diagnosing hepatitis c infection using genetically engineered lymphadenopathy associated viral protein |
| 04/29/2008 | US7364852 Using presence of short expansion sequences in poly(A) binding protein II (PAB II) gene as diagnostic indicator of disease associated with polyalanine and protein accumulation in nucleus |
| 04/29/2008 | US7364847 nucleic acid that binds to high mobility group protein-I (HMG-I), and causes presenilin-2 gene exon 5-lacked type aberrant splicing by the association with the HMG-I protein; an inhibitor for inhibiting a binding between protein-nucleic acid caused by aberrant splicing; drug screening; antisense agents |
| 04/29/2008 | US7364845 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
| 04/29/2008 | US7364744 Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV |
| 04/29/2008 | US7364743 Nucleotide sequence encoding PTD and CEA fusion protein, TAT-CEA fusion protein, anti-tumor vaccine and pharmaceutical composition for treating tumor comprising the fusion protein |
| 04/29/2008 | US7364741 Peptides of human Papilloma virus for use in human T cell response inducing compositions |
| 04/29/2008 | US7364738 Monoclonal antibodies to the CLFA protein and method of use in treating infections |
| 04/29/2008 | US7364733 antibodies that bind to Activated CD4+ T-cells (ACT-4) receptors; diagnostic or therapeutic use for immune disorders; selective suppression of immune response; allograft rejection, graft versus host disease, autoimmune diseases, allergies |
| 04/29/2008 | US7364732 Method for treating inflammation |
| 04/29/2008 | US7364730 Human K+ channel and prognosing applications thereof |
| 04/29/2008 | US7364729 Method of inducing a CTL response |
| 04/29/2008 | US7364728 Genetically engineering organisms that produce proteins lethal to larvae of insects nucleotide sequences isolated from Bacillus popilliae encode two adjacent, putative genes; orf1 and cryhime; insecticides, larvicides, pesticides; beetles |
| 04/29/2008 | US7364725 Endothelial cells engineered to express or overexpress fibulin-5 and a growth factor |
| 04/29/2008 | US7364724 Recombinant super-compound interferon |
| 04/29/2008 | CA2370098C Human beta-trcp protein |
| 04/29/2008 | CA2337667C Dextran-leptin conjugates, pharmaceutical compositions and related methods |
| 04/29/2008 | CA2315546C Constitutive maize promoters |
| 04/29/2008 | CA2285136C Coccidiosis vaccines |
| 04/29/2008 | CA2266416C Insulin c-peptides |
| 04/29/2008 | CA2242325C Fsh and lh separation and purification process |
| 04/29/2008 | CA2230372C Quantitation of p97 to diagnose and monitor alzheimer's disease |
| 04/29/2008 | CA2120353C Cell cycle controlling compositions and methods of using same |
| 04/29/2008 | CA2024487C Polygalacturonase encoding fungal expression system |
| 04/24/2008 | WO2008049070A2 Il-17c antagonists and methods of using the same |
| 04/24/2008 | WO2008048942A2 Receptor(sstr2)-selective somatostatin antagonists |
| 04/24/2008 | WO2008048784A1 Pegylated pth as pth receptor modulators and uses thereof |
| 04/24/2008 | WO2008048670A2 Compositions and methods for modulating tlr14 activity |
| 04/24/2008 | WO2008048646A1 Use of human protein c with altered glycosylation and sialic acid content as a medicament |
| 04/24/2008 | WO2008048407A2 Expression of streptomyces subtilisin inhibitor (ssi) proteins in bacillus and streptomyces sp. |
| 04/24/2008 | WO2008047966A2 Method for enhancing glycosylation of recombinant protein |
| 04/24/2008 | WO2008047936A1 LYTIC ENZYME INHIBITOR, LYSIS INHIBITOR, INHIBITOR OF DEGRADATION OF POLY-γ-GLUTAMIC ACID, AND METHOD FOR PRODUCTION OF POLY-γ-GLUTAMIC ACID |
| 04/24/2008 | WO2008047473A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 04/24/2008 | WO2008047150A2 Protein variants |
| 04/24/2008 | WO2008047111A1 Immunoglobulin domain-containing cell surface recognition molecules |
| 04/24/2008 | WO2008047006A2 Polynucleotides and polypeptides coded by said polynucleotides involved in the biosynthesis of congocidine and derivatives thereof |
| 04/24/2008 | WO2008046964A2 Novel useful inhibitors |
| 04/24/2008 | WO2008046511A1 Crtac as a biomarker, therapeutic and diagnostic target |
| 04/24/2008 | WO2008046228A1 Compounds for stimulating p-glycoprotein function and uses thereof |
| 04/24/2008 | WO2008046189A1 Proteins involved in after-cooking darkening in potatoes |
| 04/24/2008 | WO2008046182A1 Stroma derived predictor of breast cancer |
| 04/24/2008 | WO2008031045A3 Aquaretic and natriuretic polypeptides lacking vasodilatory activity |
| 04/24/2008 | WO2008025711A3 Method for increasing resistance to pathogens in transgenic plants |
| 04/24/2008 | WO2008021412A3 Interferon beta and transferrin fusion proteins |
| 04/24/2008 | WO2008015425A3 Mhc oligomers, components thereof, and methods of making the same |
| 04/24/2008 | WO2008012693A3 Recombinant mycobacterium strain expressing a mycobacterial fap protein under the control of a promoter active under hypoxia and its application for cancer therapy |
| 04/24/2008 | WO2008000881A9 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 04/24/2008 | WO2007147409A3 Ribozyme mediated stabilization of polynucleotides |
| 04/24/2008 | WO2007132355A3 Compositions and methods for inhibiting viral adhesion |
| 04/24/2008 | WO2007125127A3 Recombinantly prepared perlucin and use for preparing biomaterials |
| 04/24/2008 | WO2007124186A3 Expression control elements from the lemnaceae family |
| 04/24/2008 | WO2007112703A3 Pharmaceutical composition containing the nmb0606 protein |
| 04/24/2008 | WO2007109677A3 A novel method of protecting islet cells from apoptosis during the donor harvesting process |
| 04/24/2008 | WO2007084926A3 Compositions and methods for humanization and optimization of n-glycans in plants |
| 04/24/2008 | WO2007084711A3 Use of gr2 proteins to modify cellulosic materials and to enhance enzymatic and chemical modification of cellulose |
| 04/24/2008 | WO2005073390A3 L-amino acid-producing microorganism and method for producing l-amino acid |
| 04/24/2008 | US20080098490 Recombinant animal for use as bioreactor in production of human immunoglobulins |
| 04/24/2008 | US20080097084 Rho Antibody And Tag To Purify Cell Surface Proteins |
| 04/24/2008 | US20080097083 Granulocyte cell stimulating factor (G-CSF), erythropoietin, interferon, and growth hormone |
| 04/24/2008 | US20080097082 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 04/24/2008 | US20080097081 BH3 interacting domain death agonist for use in prevention ans treatment of apoptosis associated disorders |
| 04/24/2008 | US20080097080 Protein structure |
| 04/24/2008 | US20080096981 modulating activities associated with the IL-9 pathway for the treatment of atopic allergies like asthma; autoimmune diseases; new genes tightly expressed in association with an inflammatory response in the airways mediated by type 2 helper T-cells (TH). These genes have been designated TH2AF1 |
| 04/24/2008 | US20080096834 Administering a nucleic acid encoding a trout E-domain peptide or somatomedin as antiproliferative, anticarcinogenic and/or antitumor agent in mammals or fish |
| 04/24/2008 | US20080096833 Diagnostic drugs and kits; coded for human proto-oncogene Pim-3, an antibody specific thereto; short interence RNA; genetic engineering |
| 04/24/2008 | US20080096822 Use of the Neurotoxic Component of a Botulinum Toxin |
| 04/24/2008 | US20080096821 Cytostatin II |
| 04/24/2008 | US20080096820 Prodomain modulators of ADAM 10 |
| 04/24/2008 | US20080096818 administering polypeptides comprising beta amyloid fragments, to induce immunogenic response against amyloid deposits; prophylaxios and therapy of Alzheimer's disease |
| 04/24/2008 | US20080096816 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096815 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096814 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096813 Generation of potent dominant negative transcriptional inhibitors |
| 04/24/2008 | US20080096812 isolation of low molecular weight proteins from connective tissue of animals, by dissolving in an aqueous solution of alkali compounds, for use in foods and drugs such as anticoagulants or anticholesterol agents |
| 04/24/2008 | US20080096811 Selective vpac2 receptor peptide agonists |
| 04/24/2008 | US20080096810 Cab Molecules |
| 04/24/2008 | US20080096809 Diastereomeric Peptides Useful as Inhibitors of Membrane Protein Assembly |
| 04/24/2008 | US20080096807 Cyclic vasoactive intestinal peptide receptor-2 agonists |
| 04/24/2008 | US20080096806 Compositions and methods for inhibiting microbial adhesion |
| 04/24/2008 | US20080096805 deoxygenated, endotoxin-free and stroma-free transport proteins, incapable of binding with nitric oxide, useful as substitutes for erythrocytes in mammals and for treating disorders where oxygen delivery agents are of benefit |
| 04/24/2008 | US20080096796 Peptides That Stimulate Cell Survival and Axon Regeneration |
| 04/24/2008 | US20080096795 Novel Antiangiogenic Peptide Agents and Their Therapeutic and Diagnostic Use |
| 04/24/2008 | US20080096769 Phage displayed trp cage ligands |
| 04/24/2008 | US20080096277 Expession vector comprising nucleotide sequences which code and enhance prolamin polypeptide transcription and RNA interfereing sequence which decrease expression of preferential storage proteins in seeds |
| 04/24/2008 | US20080096275 Protein For Improving Cell-Attachment Efficiency and Use Thereof |
| 04/24/2008 | US20080096263 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus |
| 04/24/2008 | US20080096253 Methods of making nanotechnological and macromolecular biomimetic structures |
| 04/24/2008 | US20080096252 Production of IL-29 from E. coli requires that the aggregated proteins be solubilized from the insoluble inclusion bodies and renatured or refolded; Without renaturation, the specific activity of the recombinant protein will be significantly reduced; higher yields |
| 04/24/2008 | US20080096251 Gonad-stimulating peptide for use in artificial control of starfish populations |
| 04/24/2008 | US20080096250 Expression vector comprising nucleotide sequences coding inflammatory response polypeptide for use in treatment and prevention of inflammation |
| 04/24/2008 | US20080096248 Grampositive bacterial polypeptide comprising toxin translocation domain for use as therapeutic targeting tools in cosmetic and the treatment of nervous system and nervous system disorders |
| 04/24/2008 | US20080096247 Nucleic acids encoding duramycin |
| 04/24/2008 | US20080096239 Orphan Nuclear Receptor |
| 04/24/2008 | US20080096229 Filamentous receptor structure comprising D3 domain for use as components of elements |
| 04/24/2008 | US20080096215 Using sulfatase gene expression as evaluative tool in detection, prevention and treatment of cell proliferative disorders |
| 04/24/2008 | US20080096211 Expression vector comprising nucleotide sequences coding stability gene expression or protein secretion/folding (SES) proteins for enhancing production of functional heterologous polypeptides |
| 04/24/2008 | US20080096210 Cancer suppressing agent |
| 04/24/2008 | US20080095914 Novel Vegetable Protein Fractionization Process And Compositions |
| 04/24/2008 | US20080095872 using modified Clostridial toxin having an orphanin targeting moiety, a domain for translocating a light chain across an endosome membrane; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |